INSIGHTS AND PERSPECTIVES
Rethinking specialty distribution to improve patient access
Walgreens’ newly patented technology helps guide interactions with patients, helping them stay on their treatment and manage any possible side effects.
The acquisition will see Sanofi adding the Waltham, Mass.-based biopharmaceutical company’s hemophilia treatments Eloctate and Alprolix to its specialty and rare disease portfolio.
In a move aimed at helping its pharmacy benefits management clients control high specialty drug costs and improve patient outcomes, CVS Health has introduced the Transform Rheumatoid Arthritis Care program.
Fresenius Kabi has introduced its alternative of Takeda Oncology’s Velcade (bortezomib for injection).
There’s no single magic bullet for enabling patient-facing care in community-based pharmacy, but there are proven strategies to make substantial progress.